mianserin has been researched along with Bilateral Headache in 17 studies
Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.
| Excerpt | Relevance | Reference |
|---|---|---|
| "114 patients with chronic tension headache (more than 10 days per month for at least 6 months) were treated with placebo, clomipramine or mianserin in a double blind parallel group comparison." | 9.06 | Clomipramine and mianserin in the treatment of chronic tension headache. A double-blind, controlled study. ( Bech, P; Langemark, M; Loldrup, D; Olesen, J, 1990) |
| "Mood depression was evaluated at 0, 4 and 8 weeks by using Zung's Self-Rating Depression Scale and Hamilton Rating Scale for Depression." | 6.67 | Chronic tension-type headache, mood depression and serotonin: therapeutic effects of fluvoxamine and mianserine. ( Bolino, F; Di Cicco, L; Manna, V, 1994) |
| "Mirtazapine is an antidepressant with a mechanism that involves activating serotonin (5-HT1) receptors." | 6.47 | Mirtazapine relieves post-electroconvulsive therapy headaches and nausea: a case series and review of the literature. ( Huang, KC; Lee, WK; Li, TC; Shiah, IS; Sun, CJ; Tzang, RF, 2011) |
| "Primary care patients with a major depressive disorder and 17-item Hamilton Rating Scale for Depression (17-HAM-D) score >18 were randomized to 24 weeks of treatment with mirtazapine 30-45 mg/day (n=99) or paroxetine 20-30 mg/day (n=98)." | 5.10 | A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care. ( Angus, M; Crawford, GM; Hamilton, L; Wade, A; Wilson, R, 2003) |
| "114 patients with chronic tension headache (more than 10 days per month for at least 6 months) were treated with placebo, clomipramine or mianserin in a double blind parallel group comparison." | 5.06 | Clomipramine and mianserin in the treatment of chronic tension headache. A double-blind, controlled study. ( Bech, P; Langemark, M; Loldrup, D; Olesen, J, 1990) |
| "The efficacies of an 2-agonist clonidine and an 2-antagonist mianserin were compared in two treatment groups, common migraine and tension headache sufferers." | 5.05 | Headache and noradrenergic involvement: the effects of alpha 2-stimulants and alpha 2-antagonists. ( Agnoli, A; Denaro, A; Manna, V; Martucci, N; Ruggieri, S, 1985) |
| "Ninety-two outpatients with depressive disorders which met Research Diagnostic Criteria were treated either with mianserin or placebo in a 6-week controlled trial." | 5.05 | Placebo-controlled study of mianserin in depressed outpatients. ( Harrison, W; Markowitz, J; McGrath, PJ; Quitkin, FM; Rabkin, JG; Stewart, JW, 1985) |
| "Mirtazapine is a third-generation antidepressant with a dual mode of action." | 2.72 | Intravenous mirtazapine is safe and effective in the treatment of depressed inpatients. ( Egger, C; Eichberger, G; Hinterhuber, H; Hofmann, P; Kasper, S; Konstantinidis, A; Mühlbacher, M; Nickel, M; Nimmerrichter, A; Schubert, H; Stuppaeck, C, 2006) |
| "Mood depression was evaluated at 0, 4 and 8 weeks by using Zung's Self-Rating Depression Scale and Hamilton Rating Scale for Depression." | 2.67 | Chronic tension-type headache, mood depression and serotonin: therapeutic effects of fluvoxamine and mianserine. ( Bolino, F; Di Cicco, L; Manna, V, 1994) |
| "Mianserin was considered to be an effective antidepressant." | 2.65 | Multicentre evaluation of mianserin in depressive illness. ( Burrows, GD; Marriott, P; Norman, TR, 1981) |
| "Mirtazapine is an antidepressant with a mechanism that involves activating serotonin (5-HT1) receptors." | 2.47 | Mirtazapine relieves post-electroconvulsive therapy headaches and nausea: a case series and review of the literature. ( Huang, KC; Lee, WK; Li, TC; Shiah, IS; Sun, CJ; Tzang, RF, 2011) |
| " The rates for individual side effects with the serotonin selective reuptake inhibitors, nefazodone, and venlafaxine are presented and compared with the adverse event experience for mirtazapine." | 2.40 | Safety and tolerability of the new antidepressants. ( Nelson, JC, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (35.29) | 18.7374 |
| 1990's | 5 (29.41) | 18.2507 |
| 2000's | 3 (17.65) | 29.6817 |
| 2010's | 3 (17.65) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iwanowski, P | 1 |
| Kozubski, W | 1 |
| Losy, J | 1 |
| Smith, JH | 1 |
| Li, TC | 1 |
| Shiah, IS | 1 |
| Sun, CJ | 1 |
| Tzang, RF | 1 |
| Huang, KC | 1 |
| Lee, WK | 1 |
| Wade, A | 1 |
| Crawford, GM | 1 |
| Angus, M | 1 |
| Wilson, R | 1 |
| Hamilton, L | 1 |
| Mühlbacher, M | 1 |
| Konstantinidis, A | 1 |
| Kasper, S | 1 |
| Eichberger, G | 1 |
| Hinterhuber, H | 1 |
| Hofmann, P | 1 |
| Nimmerrichter, A | 1 |
| Schubert, H | 1 |
| Egger, C | 1 |
| Nickel, M | 1 |
| Stuppaeck, C | 1 |
| Lo Cascio, V | 1 |
| Adami, S | 1 |
| Tartarotti, D | 1 |
| Ferrari, S | 1 |
| Zatti, M | 1 |
| Marriott, P | 1 |
| Burrows, GD | 1 |
| Norman, TR | 1 |
| Lechin, F | 1 |
| van der Dijs, B | 1 |
| Manna, V | 3 |
| Bolino, F | 1 |
| Di Cicco, L | 1 |
| Solov'eva, AD | 1 |
| Filatova, EG | 1 |
| Voznesenskaia, TG | 1 |
| Kanavets, EV | 1 |
| Nelson, JC | 1 |
| Wheatley, DP | 1 |
| van Moffaert, M | 1 |
| Timmerman, L | 1 |
| Kremer, CM | 1 |
| Spierings, EL | 1 |
| Langemark, M | 1 |
| Loldrup, D | 1 |
| Bech, P | 1 |
| Olesen, J | 1 |
| Martucci, N | 2 |
| Porto, C | 1 |
| Agnoli, A | 2 |
| Denaro, A | 1 |
| Ruggieri, S | 1 |
| McGrath, PJ | 1 |
| Rabkin, JG | 1 |
| Stewart, JW | 1 |
| Harrison, W | 1 |
| Quitkin, FM | 1 |
| Markowitz, J | 1 |
2 reviews available for mianserin and Bilateral Headache
| Article | Year |
|---|---|
Mirtazapine relieves post-electroconvulsive therapy headaches and nausea: a case series and review of the literature.
Topics: Adult; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Electroconvulsive Therapy; Fema | 2011 |
Safety and tolerability of the new antidepressants.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressiv | 1997 |
9 trials available for mianserin and Bilateral Headache
| Article | Year |
|---|---|
A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Antidepress | 2003 |
Intravenous mirtazapine is safe and effective in the treatment of depressed inpatients.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Fatigue; Fema | 2006 |
Multicentre evaluation of mianserin in depressive illness.
Topics: Adult; Body Weight; Clinical Trials as Topic; Constipation; Depressive Disorder; Dibenzazepines; Fem | 1981 |
Chronic tension-type headache, mood depression and serotonin: therapeutic effects of fluvoxamine and mianserine.
Topics: Adult; Chronic Disease; Depression; Double-Blind Method; Female; Fluvoxamine; Headache; Humans; Male | 1994 |
Mirtazapine: efficacy and tolerability in comparison with fluoxetine in patients with moderate to severe major depressive disorder. Mirtazapine-Fluoxetine Study Group.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Tricyclic; Depressive Disorder; Drug Administration | 1998 |
Clomipramine and mianserin in the treatment of chronic tension headache. A double-blind, controlled study.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Clomipramine; Double-Blind Method; Female; Headache; | 1990 |
Migraine and the noradrenergic control of vasomotricity: a study with alpha-2 stimulant and alpha-2 blocker drugs.
Topics: Adult; Clinical Trials as Topic; Clonidine; Dibenzazepines; Double-Blind Method; Female; Headache; H | 1985 |
Headache and noradrenergic involvement: the effects of alpha 2-stimulants and alpha 2-antagonists.
Topics: Adult; Clinical Trials as Topic; Clonidine; Dibenzazepines; Double-Blind Method; Female; Headache; H | 1985 |
Placebo-controlled study of mianserin in depressed outpatients.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Depressive Disorder; Dibenzazepines; Dizziness; F | 1985 |
6 other studies available for mianserin and Bilateral Headache
| Article | Year |
|---|---|
Nummular headache in a patient with ipsilateral occipital neuralgia--a case report.
Topics: Amines; Analgesics; Anesthetics, Local; Bupivacaine; Comorbidity; Cyclohexanecarboxylic Acids; Femal | 2014 |
Mirtazapine for new daily persistent headache-associated chronic nausea.
Topics: Chronic Disease; Female; Headache; Histamine H1 Antagonists; Humans; Mianserin; Middle Aged; Mirtaza | 2015 |
Aberration in vitamin D metabolism during mianserin treatment.
Topics: Dibenzazepines; Headache; Humans; Male; Mianserin; Middle Aged; Phosphates; Vitamin D | 1984 |
Physiological, clinical and therapeutical basis of a new hypothesis for headache.
Topics: Amphetamines; Autonomic Nervous System; Headache; Humans; Levodopa; Methylphenidate; Mianserin; Nomi | 1980 |
[The clinical picture, diagnosis and therapy of headaches in patients with a hypothalamic syndrome].
Topics: Adult; Affective Symptoms; Antidepressive Agents, Second-Generation; Female; Headache; Humans; Hypot | 1995 |
Acute and chronic hypertensive headache and hypertensive encephalopathy.
Topics: Acute Disease; Antidepressive Agents; Antihypertensive Agents; Anxiety; Arterioles; Cerebral Arterie | 2002 |